UNIRETIC® 15/25 mg tablets

DRUG2 trials

Sponsors

Teva Pharmaceuticals USA

Conditions

Healthy

Phase 1

Moexipril HCl/Hydrochlorothiazide 15/25 mg Tablets Under Non-Fasting Conditions

CompletedNCT00834067

Teva Pharmaceuticals USAHealthy

Start: 2003-10-31End: 2003-11-30Updated: 2024-08-20

Moexipril HCL/Hydrochlorothiazide 15/25 mg Tablets Under Fasting Conditions

CompletedNCT00835042

Teva Pharmaceuticals USAHealthy

Start: 2003-10-31End: 2003-11-30Updated: 2024-08-20